
Cetuxa contains Cetuximab, a monoclonal antibody used to treat certain types of colorectal cancer and head & neck cancers. It works by targeting the EGFR protein on cancer cells, helping to slow tumor growth.
| Composition | Cetuximab |
| Manufacturer | ALKEM LABORATORIES LTD |
| Packing | 1 Vial(s) Of 20ml |
| Prescribed For | Colorectal, head and neck cancer |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, Japan, UAE, Saudi Arabia, Qatar, Kuwait, Georgia, Mexico, and many other countries. |




| Package | USD | GBP | AUD | NZD | PHP | KRW | RON | HKD | MYR | THB | AED |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 Vial(s) Of 20ml | $225 | £167 | A$315 | NZ$390 | ₱14,114 | ₩307,764 | lei 1,033 | HK$1,765 | RM908 | ฿7,481 | د.إ826 |
Cetuximab prices may vary between countries depending on the brand, strength, pack size, pharmacy, insurance coverage, government subsidies, taxes and local healthcare policies. The following resources provide country-specific pricing, reimbursement, regulatory or medicine information.